Free Trial

Acelyrin (SLRN) SEC Filings & 10K Form

$4.30
-0.09 (-2.05%)
(As of 04:00 PM ET)

Recent Acelyrin SEC Filings

DateFilerForm TypeView
05/17/2024
6:09 PM
Acelyrin (Issuer)
Pangali Sanam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:09 PM
Acelyrin (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:12 PM
Acelyrin (Issuer)
Gloria Melanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:05 PM
Acelyrin (Issuer)
Pangali Sanam (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/17/2024
6:08 PM
Acelyrin (Issuer)
Mpofu Shephard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2024
7:14 AM
Acelyrin (Filer)
Form DEFA14A
05/09/2024
7:13 AM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
3:10 PM
Acelyrin (Filer)
Form DEF 14A
04/22/2024
3:14 PM
Acelyrin (Filer)
Form DEFA14A
04/22/2024
3:19 PM
Acelyrin (Filer)
Form ARS
04/03/2024
5:18 PM
Acelyrin (Issuer)
Lin Shao-Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:43 PM
Acelyrin (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/28/2024
3:08 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
4:15 PM
Acelyrin (Subject)
Peloso Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
6:04 AM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:05 AM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:04 PM
Acelyrin (Issuer)
Lin Shao-Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:18 PM
Acelyrin (Subject)
CITADEL ADVISORS LLC (Filed by)
Form SC 13G/A
02/09/2024
7:35 AM
Acelyrin (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/11/2024
5:38 PM
Acelyrin (Issuer)
Oyston Ronald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:42 PM
Acelyrin (Issuer)
Lin Shao-Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:26 PM
Acelyrin (Issuer)
Labrucherie Gil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:31 PM
Acelyrin (Issuer)
Gloria Melanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:34 PM
Acelyrin (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:09 PM
Acelyrin (Issuer)
Lin Shao-Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
4:49 PM
Acelyrin (Issuer)
TETRAULT LYNN A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2023
4:53 PM
Acelyrin (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:38 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
3:31 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
3:23 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
8:09 AM
Acelyrin (Subject)
FIL Ltd (Filed by)
Form SC 13G
10/06/2023
4:53 PM
Acelyrin (Issuer)
Labrucherie Gil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
4:55 PM
Acelyrin (Issuer)
Peloso Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
4:55 PM
Acelyrin (Issuer)
Lin Shao-Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
4:56 PM
Acelyrin (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
3:48 PM
Acelyrin (Issuer)
Labrucherie Gil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:49 PM
Acelyrin (Issuer)
Lin Shao-Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:50 PM
Acelyrin (Issuer)
Gloria Melanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:52 PM
Acelyrin (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:54 PM
Acelyrin (Issuer)
Peloso Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:55 PM
Acelyrin (Issuer)
Oyston Ronald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)

Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!

Click for Zack's full report
08/14/2023
3:19 PM
Acelyrin (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
3:22 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
7:08 PM
Acelyrin (Issuer)
Labrucherie Gil M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/15/2023
3:22 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SLRN) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners